Free Trial

MCCORMICK & CO/SH SH (MKC.V) Financials

$46.92 +0.70 (+1.50%)
Closing price 10/5/2026 03:58 PM Eastern
Extended Trading
$46.66 -0.25 (-0.54%)
As of 04:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for MCCORMICK & CO/SH SH

Annual Income Statements for MCCORMICK & CO/SH SH

This table shows MCCORMICK & CO/SH SH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 11/30/2015 11/30/2016 11/30/2017 11/30/2018 11/30/2019 11/30/2020 11/30/2021 11/30/2022 11/30/2023 11/30/2024 11/30/2025
Net Income / (Loss) Attributable to Common Shareholders
767 909 477 933 703 747 1,458 1,326 1,305 1,503 1,507
Consolidated Net Income / (Loss)
402 472 477 933 703 747 755 682 681 789 789
Net Income / (Loss) Continuing Operations
402 472 477 933 703 747 755 682 681 789 789
Total Pre-Tax Income
496 589 595 741 819 882 896 813 799 898 913
Total Operating Income
548 641 700 891 958 1,000 1,015 864 963 1,060 1,071
Total Gross Profit
1,737 1,832 1,794 2,093 2,145 2,300 2,495 2,275 2,503 2,591 2,592
Total Revenue
4,296 4,412 4,730 5,303 5,347 5,601 6,318 6,351 6,662 6,724 6,840
Operating Revenue
4,296 4,412 4,730 5,303 5,347 5,601 6,318 6,351 6,662 6,724 6,840
Total Cost of Revenue
2,559 2,580 2,936 3,210 3,202 3,301 3,823 4,076 4,160 4,133 4,248
Operating Cost of Revenue
2,559 2,580 2,936 3,210 3,202 3,301 3,823 4,076 4,160 4,133 4,248
Total Operating Expenses
1,189 1,191 1,094 1,202 1,188 1,301 1,480 1,411 1,540 1,531 1,521
Selling, General & Admin Expense
1,127 1,175 1,031 1,163 1,167 1,282 1,404 1,357 1,478 1,521 1,500
Other Special Charges / (Income)
62 16 22 16 21 6.90 46 52 61 9.50 21
Total Other Income / (Expense), net
-52 -52 -105 -150 -139 -118 -119 -51 -164 -162 -158
Interest Expense
53 56 96 175 165 136 137 149 208 209 196
Other Income / (Expense), net
1.10 4.20 -9.30 25 27 18 17 98 44 47 38
Income Tax Expense
131 153 151 -157 157 175 193 169 175 184 196
Other Gains / (Losses), net
37 36 34 35 41 41 52 38 56 74 72
Net Income / (Loss) Attributable to Noncontrolling Interest
-365 -436 - - - - -703 -644 -624 -714 -717
Basic Earnings per Share
$3.14 $3.73 $3.77 $3.55 $2.65 $2.80 $2.83 $2.54 $2.54 $2.94 $2.94
Weighted Average Basic Shares Outstanding
128M 126.60M 126.80M 131.50M 132.91M 266.94M 267.53M 268.10M 268.24M 268.15M 268.44M
Diluted Earnings per Share
$3.11 $3.69 $3.72 $3.50 $2.62 $2.78 $2.80 $2.52 $2.52 $2.92 $2.93
Weighted Average Diluted Shares Outstanding
128M 126.60M 126.80M 131.50M 132.91M 266.94M 267.53M 268.10M 268.24M 268.15M 268.44M
Weighted Average Basic & Diluted Shares Outstanding
128M 126.60M 126.80M 131.50M 132.91M 266.94M 267.53M 268.10M 268.24M 268.15M 268.44M
Cash Dividends to Common per Share
$1.60 $1.72 $1.88 $2.08 $2.28 $1.24 $1.36 $1.48 $1.56 $1.68 $1.80

Quarterly Income Statements for MCCORMICK & CO/SH SH

This table shows MCCORMICK & CO/SH SH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
Net Income / (Loss) Attributable to Common Shareholders
311 352 428 724 162 175 226 435 1,016 150 98
Consolidated Net Income / (Loss)
166 184 223 215 163 176 228 227 1,022 160 108
Net Income / (Loss) Continuing Operations
166 184 223 215 145 176 228 227 136 160 108
Total Pre-Tax Income
194 194 246 264 187 205 248 274 185 220 155
Total Operating Income
234 234 287 306 225 246 289 311 228 276 217
Total Gross Profit
599 620 650 722 604 623 645 720 709 778 795
Total Revenue
1,603 1,643 1,680 1,798 1,606 1,660 1,725 1,850 1,874 1,937 2,025
Operating Revenue
1,603 1,643 1,680 1,798 1,606 1,660 1,725 1,850 1,874 1,937 2,025
Total Cost of Revenue
1,003 1,024 1,030 1,076 1,002 1,037 1,080 1,130 1,165 1,158 1,230
Operating Cost of Revenue
1,003 1,024 1,030 1,076 1,002 1,037 1,080 1,130 1,165 1,158 1,230
Total Operating Expenses
366 386 363 416 379 377 356 409 481 502 578
Selling, General & Admin Expense
362 384 362 414 379 364 353 405 456 442 436
Other Special Charges / (Income)
4.20 1.80 1.90 1.60 0.00 13 3.90 4.40 25 60 142
Total Other Income / (Expense), net
-39 -41 -40 -42 -39 -41 -41 -37 -43 -56 -63
Interest Expense
50 53 54 53 49 51 50 47 47 63 68
Other Income / (Expense), net
11 12 13 11 9.80 9.80 9.40 9.40 4.80 6.50 5.90
Income Tax Expense
50 26 41 67 42 49 39 66 49 64 50
Other Gains / (Losses), net
21 17 18 18 - 21 19 18 - 3.50 3.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-145 -167 -205 - 1.10 1.00 2.20 -208 6.10 10 10
Basic Earnings per Share
$0.62 $0.69 $0.83 $0.80 $0.60 $0.65 $0.84 $0.85 $3.78 $0.56 $0.36
Weighted Average Basic Shares Outstanding
268.40M 268.60M 268.60M 268.15M 268.30M 268.60M 268.60M 268.44M 268.80M 269.20M 269.30M
Diluted Earnings per Share
$0.62 $0.68 $0.83 $0.79 $0.60 $0.65 $0.84 $0.84 $3.77 $0.56 $0.36
Weighted Average Diluted Shares Outstanding
269.60M 269.70M 269.70M 268.15M 269.50M 269.40M 269.30M 268.44M 269.40M 269.20M 269.40M
Weighted Average Basic & Diluted Shares Outstanding
268.41M 268.63M 268.36M 268.15M 268.19M 268.37M 268.38M 268.44M 268.72M 268.85M 269.06M
Cash Dividends to Common per Share
$0.42 $0.84 $0.84 - $0.45 $0.45 $0.45 - $0.48 $0.48 $0.48

Annual Cash Flow Statements for MCCORMICK & CO/SH SH

This table details how cash moves in and out of MCCORMICK & CO/SH SH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 11/30/2015 11/30/2016 11/30/2017 11/30/2018 11/30/2019 11/30/2020 11/30/2021 11/30/2022 11/30/2023 11/30/2024 11/30/2025
Net Change in Cash & Equivalents
35 5.80 68 -88 50 268 -72 -18 -167 20 -90
Net Cash From Operating Activities
590 658 815 821 947 1,041 828 652 1,237 922 962
Net Cash From Continuing Operating Activities
590 658 815 821 947 1,041 828 652 1,237 922 962
Net Income / (Loss) Continuing Operations
402 472 477 933 703 747 755 682 681 789 789
Consolidated Net Income / (Loss)
402 472 477 933 703 747 755 682 681 789 789
Depreciation Expense
106 109 125 151 159 165 186 201 199 209 231
Non-Cash Adjustments To Reconcile Net Income
46 36 55 -294 26 38 67 2.80 94 38 32
Changes in Operating Assets and Liabilities, net
37 42 158 31 59 91 -187 -234 264 -113 -90
Net Cash From Investing Activities
-339 -267 -4,508 -159 -171 -1,026 -909 -146 -261 -269 -255
Net Cash From Continuing Investing Activities
-339 -267 -4,508 -159 -171 -1,026 -909 -146 -261 -269 -255
Purchase of Property, Plant & Equipment
-128 -154 -182 -169 -174 -225 -278 -262 -264 -275 -222
Acquisitions
-211 -121 -4,327 -4.20 0.00 -803 -706 - 0.00 0.00 -34
Divestitures
0.00 4.20 - - 0.00 0.00 65 109 1.00 0.00 0.00
Other Investing Activities, net
0.00 1.40 1.50 15 2.70 2.70 10 6.80 2.40 5.90 0.70
Net Cash From Financing Activities
-200 -372 3,756 -751 -726 221 22 -487 -1,184 -583 -841
Net Cash From Continuing Financing Activities
-200 -372 3,756 -751 -726 221 22 -487 -1,184 -583 -841
Repayment of Debt
-129 -202 -415 -798 -448 28 -606 -74 -1,232 -583 -334
Repurchase of Common Equity
-146 -243 -138 -62 -95 -47 -8.60 -39 -36 -53 -35
Payment of Dividends
-205 -218 -238 -286 -302 -330 -363 -397 -419 -451 -483
Issuance of Debt
247 258 3,990 331 41 527 1,002 0.00 496 496 2.70
Other Financing Activities, net
33 33 2.80 64 78 44 -1.90 22 5.80 8.50 7.70
Effect of Exchange Rate Changes
-16 -14 5.40 - - 32 -14 -36 40 -50 44

Quarterly Cash Flow Statements for MCCORMICK & CO/SH SH

This table details how cash moves in and out of MCCORMICK & CO/SH SH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
Net Change in Cash & Equivalents
11 -12 35 -15 -83 21 -29 1.00 82 154 -0.10
Net Cash From Operating Activities
138 163 162 459 116 46 259 542 51 380 168
Net Cash From Continuing Operating Activities
138 163 162 459 116 46 259 542 51 380 168
Net Income / (Loss) Continuing Operations
166 184 223 215 163 175 226 227 1,022 160 108
Consolidated Net Income / (Loss)
166 184 223 215 163 175 226 227 1,022 160 108
Depreciation Expense
46 57 55 51 54 57 61 59 63 74 77
Non-Cash Adjustments To Reconcile Net Income
17 20 3.30 -2.60 9.80 4.20 7.60 9.10 -851 5.70 48
Changes in Operating Assets and Liabilities, net
-90 -99 -119 195 -112 -190 -36 247 -198 140 -64
Net Cash From Investing Activities
-62 -68 -59 -80 -37 -68 -67 -83 -762 -43 -56
Net Cash From Continuing Investing Activities
-62 -68 -59 -80 -37 -68 -67 -83 -762 -43 -56
Purchase of Property, Plant & Equipment
-62 -68 -59 -86 -37 -48 -53 -84 -33 -43 -56
Net Cash From Financing Activities
-68 -105 -34 -377 -155 12 -235 -463 782 -179 -112
Net Cash From Continuing Financing Activities
-68 -105 -34 -377 -155 12 -235 -463 782 -179 -112
Repayment of Debt
-12 68 101 -741 -17 115 -115 -342 421 -40 18
Payment of Dividends
-113 -113 -113 -113 -121 -121 -121 -121 -129 -137 -142
Issuance of Debt
57 -57 - 496 0.00 27 1.50 0.30 497 0.30 0.60
Other Financing Activities, net
-0.50 2.00 2.40 4.60 0.00 0.70 1.20 5.80 3.40 -1.70 10
Effect of Exchange Rate Changes
- - -35 -16 -6.50 - 14 4.60 12 -4.60 0.20

Annual Balance Sheets for MCCORMICK & CO/SH SH

This table presents MCCORMICK & CO/SH SH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 11/30/2015 11/30/2016 11/30/2017 11/30/2018 11/30/2019 11/30/2020 11/30/2021 11/30/2022 11/30/2023 11/30/2024 11/30/2025
Total Assets
4,473 1,187 10,386 10,256 10,362 12,090 12,906 13,125 12,862 13,070 13,200
Total Current Assets
1,357 838 1,617 1,480 1,550 2,084 2,196 2,387 2,002 2,139 2,138
Cash & Equivalents
113 - 187 97 155 424 352 334 167 186 96
Accounts Receivable
455 - 555 518 503 529 550 574 588 587 629
Inventories, net
711 756 793 786 801 1,033 1,182 1,340 1,127 1,240 1,272
Prepaid Expenses
79 82 82 79 91 99 112 139 121 126 141
Plant, Property, & Equipment, net
618 0.00 809 942 953 1,028 1,140 1,198 1,325 1,413 1,449
Total Noncurrent Assets
2,497 348 7,960 7,835 7,859 8,978 9,570 9,540 9,536 9,518 9,614
Long-Term Investments
365 348 399 434 507 752 781 939 919 972 1,019
Goodwill
1,759 - 4,490 4,528 4,505 4,986 5,336 5,213 5,260 5,228 5,301
Intangible Assets
372 - 3,071 2,873 2,847 3,239 3,453 3,388 3,357 3,319 3,293
Total Liabilities & Shareholders' Equity
4,473 1,164 10,386 10,256 10,362 12,090 12,906 13,125 12,862 13,070 13,200
Total Liabilities
2,786 80 7,815 7,074 6,905 8,150 8,480 8,426 7,779 7,754 7,432
Total Current Liabilities
1,239 0.00 1,947 2,002 2,154 3,047 3,224 3,432 3,099 2,883 3,062
Short-Term Debt
343 - 583 644 698 1,151 1,309 1,507 1,072 748 891
Accounts Payable
412 - 640 710 847 1,032 1,064 1,171 1,119 1,238 1,259
Accrued Expenses
484 - 724 648 609 864 850 754 908 896 912
Total Noncurrent Liabilities
1,547 80 5,868 5,073 4,751 5,103 5,257 4,993 4,680 4,871 4,370
Long-Term Debt
1,051 - 4,444 4,053 3,626 3,754 3,973 3,642 3,340 3,594 3,106
Noncurrent Deferred & Payable Income Tax Liabilities
- 80 1,095 707 698 727 792 866 861 841 836
Other Noncurrent Operating Liabilities
496 - 329 313 428 622 491 485 479 437 429
Total Equity & Noncontrolling Interests
1,687 1,084 2,571 3,182 3,457 3,940 4,426 4,699 5,084 5,317 5,768
Total Preferred & Common Equity
1,670 1,084 2,560 3,171 3,444 3,926 4,411 4,681 5,061 5,291 5,737
Total Common Equity
1,670 1,084 2,560 3,171 3,444 3,926 4,411 4,681 5,061 5,291 5,737
Common Stock
1,040 1,084 1,673 1,771 1,889 1,981 2,055 2,139 2,200 2,237 2,283
Retained Earnings
1,037 - 1,167 1,760 2,056 2,416 2,782 3,023 3,250 3,545 3,816
Accumulated Other Comprehensive Income / (Loss)
-406 - -280 -360 -500 -471 -427 -481 -389 -491 -363
Noncontrolling Interest
17 - 11 11 13 14 15 19 23 26 32

Quarterly Balance Sheets for MCCORMICK & CO/SH SH

This table presents MCCORMICK & CO/SH SH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 2/28/2026 5/31/2026 8/31/2026
Total Assets
12,862 12,890 12,988 13,205 13,070 12,900 13,190 13,247 16,346 16,477 16,651
Total Current Assets
2,002 2,020 2,069 2,244 2,139 2,013 2,166 2,224 2,609 2,789 2,905
Cash & Equivalents
167 178 166 201 186 103 124 95 178 331 331
Accounts Receivable
588 568 599 661 587 517 585 669 829 709 832
Inventories, net
1,127 1,130 1,158 1,243 1,240 1,246 1,308 1,324 1,367 1,409 1,446
Prepaid Expenses
121 145 146 140 126 147 150 137 236 340 296
Plant, Property, & Equipment, net
1,325 1,355 1,366 1,400 1,413 1,393 1,417 1,420 1,510 1,504 1,538
Total Noncurrent Assets
9,536 9,515 9,552 9,561 9,518 9,494 9,607 9,603 12,227 12,184 12,208
Long-Term Investments
919 915 956 951 972 980 1,007 987 949 955 945
Goodwill
5,260 5,254 5,257 5,278 5,228 5,206 5,292 5,314 6,317 6,292 6,304
Intangible Assets
3,357 3,347 3,339 3,333 3,319 3,308 3,309 3,303 4,962 4,938 4,959
Total Liabilities & Shareholders' Equity
12,862 12,890 12,988 13,205 13,070 12,900 13,190 13,247 16,346 16,477 16,651
Total Liabilities
7,779 7,633 7,633 7,754 7,754 7,450 7,560 7,463 8,790 8,904 9,064
Total Current Liabilities
3,099 2,974 2,984 3,144 2,883 3,102 3,186 3,120 3,442 3,572 4,420
Short-Term Debt
1,072 1,128 1,139 1,245 748 1,212 1,356 1,253 1,319 1,336 2,112
Accounts Payable
1,119 1,133 1,210 1,228 1,238 1,162 1,178 1,197 1,392 1,515 1,481
Accrued Expenses
908 713 635 672 896 728 652 670 731 721 827
Total Noncurrent Liabilities
4,680 4,659 4,649 4,610 4,871 4,348 4,374 4,343 5,348 5,332 4,644
Long-Term Debt
3,340 3,329 3,326 3,343 3,594 3,096 3,099 3,105 3,604 3,597 2,906
Noncurrent Deferred & Payable Income Tax Liabilities
861 858 851 836 841 830 823 822 1,324 1,327 1,323
Other Noncurrent Operating Liabilities
479 472 472 430 437 423 452 416 420 408 414
Total Equity & Noncontrolling Interests
5,084 5,257 5,354 5,451 5,317 5,450 5,630 5,784 7,556 7,573 7,587
Total Preferred & Common Equity
5,061 5,233 5,327 5,422 5,291 5,423 5,601 5,753 6,980 6,996 7,003
Total Common Equity
5,061 5,233 5,327 5,422 5,291 5,423 5,601 5,753 6,980 6,996 7,003
Common Stock
2,200 2,213 2,235 2,235 2,237 2,253 2,264 2,272 2,306 2,314 2,330
Retained Earnings
3,250 3,413 3,480 3,577 3,545 3,694 3,739 3,842 4,823 4,843 4,812
Accumulated Other Comprehensive Income / (Loss)
-389 -394 -388 -390 -491 -525 -401 -361 -149 -161 -138
Noncontrolling Interest
23 25 27 30 26 27 29 31 576 578 584

Annual Metrics And Ratios for MCCORMICK & CO/SH SH

This table displays calculated financial ratios and metrics derived from MCCORMICK & CO/SH SH's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 11/30/2015 11/30/2016 11/30/2017 11/30/2018 11/30/2019 11/30/2020 11/30/2021 11/30/2022 11/30/2023 11/30/2024 11/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.25% 2.68% 7.23% 12.10% 0.84% 4.75% 12.79% 0.52% 4.91% 0.92% 1.73%
EBITDA Growth
-7.27% 15.03% 8.20% 30.76% 7.18% 3.40% 3.63% -5.10% 3.76% 9.14% 1.82%
EBIT Growth
-9.04% 17.42% 7.02% 32.64% 7.48% 3.32% 1.50% -6.83% 4.68% 10.01% 0.14%
NOPAT Growth
-9.23% 17.67% 9.96% 107.02% -28.37% 3.55% -0.56% -14.09% 9.96% 12.03% -0.23%
Net Income Growth
-8.29% 17.60% 1.08% 95.52% -24.72% 6.36% 1.06% -9.70% -0.21% 15.85% 0.11%
EPS Growth
-6.89% 18.65% 0.81% 95.52% -24.72% 6.36% 0.72% -10.00% 0.00% 15.87% 0.34%
Operating Cash Flow Growth
17.16% 11.54% 23.89% 0.72% 15.29% 9.98% -20.46% -21.34% 89.92% -25.49% 4.37%
Free Cash Flow Firm Growth
-8.12% 388.75% -347.14% 112.99% 34.75% -75.01% -143.69% 724.45% 34.31% -18.22% -7.86%
Invested Capital Growth
-2.67% -70.87% 824.79% 4.78% -3.13% 7.73% 11.82% 0.00% -1.94% 1.09% 1.75%
Revenue Q/Q Growth
0.66% 0.57% 3.50% 1.55% 0.32% 1.32% 2.81% -0.54% 0.86% 0.68% 0.77%
EBITDA Q/Q Growth
2.31% 1.10% 5.21% 5.31% 0.48% -2.18% 0.62% -0.31% 2.92% 0.68% 0.87%
EBIT Q/Q Growth
2.27% 1.41% 4.73% 5.81% 0.39% -2.55% 0.15% -0.91% 3.89% 0.59% 0.33%
NOPAT Q/Q Growth
0.22% 1.09% 8.90% 2.47% -0.53% -1.72% 0.19% -1.38% 3.97% -0.38% 0.99%
Net Income Q/Q Growth
0.30% 1.77% 3.99% 4.28% -0.09% -1.67% -0.44% -1.69% 5.19% -0.52% 1.47%
EPS Q/Q Growth
0.32% 2.22% 3.05% 4.28% -0.09% -1.67% -1.41% -51.63% -53.25% -0.68% 1.74%
Operating Cash Flow Q/Q Growth
8.38% 10.46% 27.65% -8.89% 2.16% -3.49% 5.18% -7.65% 16.56% -11.39% 9.48%
Free Cash Flow Firm Q/Q Growth
17.93% 394.11% -1,296.39% 111.35% 5.59% -76.95% 87.73% -3.83% 10.28% 8.73% 4.93%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -3.52% -4.37% 6.94% -3.21% -3.01% -3.70% -4.35% -4.54%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
40.44% 41.52% 37.93% 39.48% 40.12% 41.07% 39.48% 35.82% 37.56% 38.54% 37.90%
EBITDA Margin
15.26% 17.09% 17.24% 20.11% 21.38% 21.10% 19.39% 18.31% 18.11% 19.58% 19.60%
Operating Margin
12.76% 14.53% 14.79% 16.80% 17.91% 17.84% 16.07% 13.60% 14.45% 15.77% 15.65%
EBIT Margin
12.79% 14.63% 14.60% 17.27% 18.41% 18.16% 16.34% 15.15% 15.11% 16.47% 16.22%
Profit (Net Income) Margin
9.35% 10.71% 10.09% 17.60% 13.14% 13.34% 11.95% 10.74% 10.22% 11.73% 11.54%
Tax Burden Percent
80.94% 80.16% 80.26% 125.91% 85.78% 84.79% 84.32% 83.91% 85.21% 87.78% 86.46%
Interest Burden Percent
90.30% 91.32% 86.14% 80.94% 83.22% 86.67% 86.77% 84.50% 79.32% 81.10% 82.31%
Effective Tax Rate
26.46% 25.97% 25.44% -21.22% 19.21% 19.84% 21.51% 20.74% 21.85% 20.48% 21.45%
Return on Invested Capital (ROIC)
15.28% 28.23% 13.43% 15.04% 10.70% 10.84% 9.81% 7.98% 8.86% 9.97% 9.81%
ROIC Less NNEP Spread (ROIC-NNEP)
15.09% 27.47% 11.27% 11.63% 8.88% 9.38% 8.76% 7.92% 6.86% 8.29% 8.10%
Return on Net Nonoperating Assets (RNNOA)
7.69% 5.85% 12.69% 17.41% 10.47% 9.37% 8.25% 6.97% 5.05% 5.19% 4.43%
Return on Equity (ROE)
22.97% 34.09% 26.12% 32.45% 21.17% 20.21% 18.06% 14.95% 13.91% 15.16% 14.24%
Cash Return on Invested Capital (CROIC)
17.98% 138.00% -147.54% 10.37% 13.87% 3.39% -1.35% 7.98% 10.82% 8.89% 8.08%
Operating Return on Assets (OROA)
12.37% 22.80% 11.93% 8.87% 9.55% 9.06% 8.26% 7.39% 7.75% 8.54% 8.44%
Return on Assets (ROA)
9.04% 16.69% 8.25% 9.04% 6.82% 6.66% 6.04% 5.24% 5.24% 6.08% 6.01%
Return on Common Equity (ROCE)
22.75% 33.88% 26.04% 32.32% 21.09% 20.14% 18.00% 14.89% 13.86% 15.09% 14.17%
Return on Equity Simple (ROE_SIMPLE)
24.05% 43.56% 18.65% 29.44% 20.40% 19.04% 17.12% 14.57% 13.45% 14.90% 0.00%
Net Operating Profit after Tax (NOPAT)
403 475 522 1,080 774 801 797 684 753 843 841
NOPAT Margin
9.39% 10.76% 11.03% 20.37% 14.47% 14.30% 12.61% 10.78% 11.30% 12.54% 12.30%
Net Nonoperating Expense Percent (NNEP)
0.19% 0.76% 2.16% 3.41% 1.81% 1.46% 1.05% 0.06% 2.00% 1.68% 1.71%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 6.95% 7.93% 8.73% 8.61%
Cost of Revenue to Revenue
59.56% 58.48% 62.07% 60.52% 59.88% 58.93% 60.52% 64.18% 62.44% 61.46% 62.10%
SG&A Expenses to Revenue
26.24% 26.63% 21.80% 21.94% 21.82% 22.88% 22.22% 21.37% 22.19% 22.62% 21.93%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
27.67% 26.99% 23.13% 22.67% 22.21% 23.23% 23.42% 22.22% 23.11% 22.77% 22.24%
Earnings before Interest and Taxes (EBIT)
550 645 691 916 984 1,017 1,032 962 1,007 1,108 1,109
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
655 754 816 1,067 1,143 1,182 1,225 1,163 1,206 1,317 1,341
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.71 9.35 4.70 5.70 6.07 5.99 4.98 4.65 3.34 3.95 3.14
Price to Tangible Book Value (P/TBV)
0.00 9.35 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.22 2.30 2.54 3.41 3.91 4.20 3.48 3.43 2.54 3.11 2.63
Price to Earnings (P/E)
12.44 11.16 25.21 19.38 29.76 31.48 15.07 16.41 12.95 13.92 11.94
Dividend Yield
2.15% 2.14% 2.05% 1.51% 1.45% 1.41% 1.65% 1.82% 2.48% 2.16% 2.69%
Earnings Yield
8.04% 8.96% 3.97% 5.16% 3.36% 3.18% 6.64% 6.09% 7.72% 7.18% 8.38%
Enterprise Value to Invested Capital (EV/IC)
4.02 12.91 2.35 3.03 3.45 3.56 3.05 2.99 2.41 2.84 2.42
Enterprise Value to Revenue (EV/Rev)
2.44 2.22 3.49 4.20 4.60 4.87 4.14 4.04 3.04 3.59 3.06
Enterprise Value to EBITDA (EV/EBITDA)
15.97 12.99 20.22 20.88 21.50 23.07 21.34 22.07 16.79 18.33 15.59
Enterprise Value to EBIT (EV/EBIT)
19.05 15.18 23.88 24.31 24.97 26.81 25.32 26.67 20.11 21.78 18.84
Enterprise Value to NOPAT (EV/NOPAT)
25.95 20.64 31.60 20.61 31.78 34.03 32.81 37.49 26.91 28.62 24.84
Enterprise Value to Operating Cash Flow (EV/OCF)
17.74 14.88 20.23 27.11 25.97 26.19 31.56 39.38 16.37 26.17 21.72
Enterprise Value to Free Cash Flow (EV/FCFF)
22.05 4.22 0.00 29.90 24.50 108.73 0.00 37.50 22.04 32.11 30.18
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.83 0.00 1.96 1.48 1.25 1.24 1.19 1.10 0.87 0.82 0.69
Long-Term Debt to Equity
0.62 0.00 1.73 1.27 1.05 0.95 0.90 0.78 0.66 0.68 0.54
Financial Leverage
0.51 0.21 1.13 1.50 1.18 1.00 0.94 0.88 0.74 0.63 0.55
Leverage Ratio
2.54 2.04 3.17 3.59 3.11 3.04 2.99 2.85 2.66 2.49 2.37
Compound Leverage Factor
2.30 1.87 2.73 2.90 2.58 2.63 2.59 2.41 2.11 2.02 1.95
Debt to Total Capital
45.25% 0.00% 66.16% 59.61% 55.57% 55.45% 54.41% 52.29% 46.46% 44.95% 40.93%
Short-Term Debt to Total Capital
11.13% 0.00% 7.68% 8.17% 8.98% 13.01% 13.49% 15.30% 11.29% 7.75% 9.12%
Long-Term Debt to Total Capital
34.12% 0.00% 58.49% 51.44% 46.60% 42.44% 40.93% 36.98% 35.18% 37.21% 31.81%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.54% 0.00% 0.14% 0.14% 0.16% 0.16% 0.15% 0.19% 0.24% 0.27% 0.32%
Common Equity to Total Capital
54.20% 100.00% 33.69% 40.25% 44.26% 44.39% 45.44% 47.52% 53.30% 54.78% 58.75%
Debt to EBITDA
2.13 0.00 6.16 4.40 3.78 4.15 4.31 4.43 3.66 3.30 2.98
Net Debt to EBITDA
1.40 0.00 5.45 3.91 3.20 3.15 3.39 3.33 2.76 2.42 2.15
Long-Term Debt to EBITDA
1.60 0.00 5.45 3.80 3.17 3.18 3.24 3.13 2.77 2.73 2.32
Debt to NOPAT
3.46 0.00 9.63 4.35 5.59 6.12 6.63 7.52 5.86 5.15 4.75
Net Debt to NOPAT
2.27 0.00 8.51 3.86 4.73 4.65 5.21 5.66 4.42 3.78 3.43
Long-Term Debt to NOPAT
2.61 0.00 8.52 3.75 4.69 4.69 4.99 5.32 4.44 4.26 3.69
Altman Z-Score
3.78 82.51 1.72 2.53 2.85 2.66 2.51 2.50 2.33 2.72 2.57
Noncontrolling Interest Sharing Ratio
0.97% 0.60% 0.30% 0.39% 0.36% 0.36% 0.34% 0.36% 0.42% 0.47% 0.52%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.10 0.00 0.83 0.74 0.72 0.68 0.68 0.70 0.65 0.74 0.70
Quick Ratio
0.46 0.00 0.38 0.31 0.31 0.31 0.28 0.26 0.24 0.27 0.24
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
475 2,320 -5,733 745 1,003 251 -110 684 919 752 692
Operating Cash Flow to CapEx
460.94% 432.68% 446.98% 485.63% 545.08% 462.18% 297.95% 248.66% 468.85% 335.36% 433.81%
Free Cash Flow to Firm to Interest Expense
8.90 41.42 -59.90 4.27 6.07 1.85 -0.80 4.59 4.41 3.59 3.53
Operating Cash Flow to Interest Expense
11.07 11.75 8.52 4.70 5.73 7.68 6.06 4.37 5.94 4.40 4.90
Operating Cash Flow Less CapEx to Interest Expense
8.67 9.04 6.61 3.73 4.68 6.02 4.03 2.61 4.68 3.09 3.77
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.97 1.56 0.82 0.51 0.52 0.50 0.51 0.49 0.51 0.52 0.52
Accounts Receivable Turnover
9.06 0.00 0.00 9.88 10.47 10.86 11.72 11.31 11.47 11.45 11.25
Inventory Turnover
3.59 3.52 3.79 4.06 4.03 3.60 3.45 3.23 3.37 3.49 3.38
Fixed Asset Turnover
7.04 0.00 0.00 6.06 5.65 5.66 5.83 5.43 5.28 4.91 4.78
Accounts Payable Turnover
6.53 0.00 0.00 4.76 4.11 3.51 3.65 3.65 3.63 3.51 3.40
Days Sales Outstanding (DSO)
40.30 0.00 0.00 36.94 34.85 33.60 31.14 32.28 31.81 31.89 32.45
Days Inventory Outstanding (DIO)
101.60 103.79 96.31 89.82 90.48 101.39 105.73 112.94 108.22 104.50 107.91
Days Payable Outstanding (DPO)
55.91 0.00 0.00 76.76 88.73 103.90 100.07 100.08 100.48 104.10 107.29
Cash Conversion Cycle (CCC)
85.99 103.79 96.31 50.00 36.59 31.09 36.79 45.14 39.54 32.29 33.07
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,603 758 7,013 7,348 7,118 7,669 8,575 8,575 8,409 8,501 8,649
Invested Capital Turnover
1.63 2.62 1.22 0.74 0.74 0.76 0.78 0.74 0.78 0.80 0.80
Increase / (Decrease) in Invested Capital
-71 -1,845 6,254 336 -230 550 906 0.30 -166 92 149
Enterprise Value (EV)
10,466 9,793 16,490 22,266 24,584 27,268 26,138 25,658 20,252 24,129 20,897
Market Capitalization
9,532 10,141 12,037 18,089 20,910 23,525 21,974 21,764 16,904 20,919 17,984
Book Value per Share
$13.04 $8.60 $19.54 $24.08 $25.91 $29.43 $16.50 $17.45 $18.86 $19.72 $21.37
Tangible Book Value per Share
($3.60) $8.60 ($38.18) ($32.13) ($29.40) ($32.23) ($16.37) ($14.62) ($13.25) ($12.13) ($10.65)
Total Capital
3,081 1,084 7,598 7,879 7,781 8,844 9,708 9,849 9,495 9,659 9,764
Total Debt
1,394 0.00 5,027 4,696 4,324 4,904 5,283 5,150 4,411 4,342 3,996
Total Long-Term Debt
1,051 0.00 4,444 4,053 3,626 3,754 3,973 3,642 3,340 3,594 3,106
Net Debt
916 -348 4,442 4,166 3,662 3,729 4,150 3,876 3,326 3,184 2,881
Capital Expenditures (CapEx)
128 152 182 169 174 225 278 262 264 275 222
Debt-free, Cash-free Net Working Capital (DFCFNWC)
349 838 66 25 -61 -236 -70 128 -192 -182 -130
Debt-free Net Working Capital (DFNWC)
462 838 253 122 94 188 281 462 -26 4.50 -34
Net Working Capital (NWC)
119 838 -330 -522 -604 -963 -1,028 -1,046 -1,097 -744 -924
Net Nonoperating Expense (NNE)
1.69 2.25 44 147 71 54 41 2.46 72 55 52
Net Nonoperating Obligations (NNO)
916 -326 4,442 4,166 3,662 3,729 4,150 3,876 3,326 3,184 2,881
Total Depreciation and Amortization (D&A)
106 109 125 151 159 165 193 201 199 209 231
Debt-free, Cash-free Net Working Capital to Revenue
8.13% 19.00% 1.40% 0.47% -1.14% -4.21% -1.11% 2.01% -2.89% -2.70% -1.89%
Debt-free Net Working Capital to Revenue
10.75% 19.00% 5.35% 2.30% 1.76% 3.35% 4.45% 7.27% -0.39% 0.07% -0.49%
Net Working Capital to Revenue
2.77% 19.00% -6.98% -9.84% -11.30% -17.19% -16.27% -16.47% -16.47% -11.06% -13.51%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.89 $3.55 $2.65 $2.80 $2.83 $2.54 $2.54 $2.94 $2.94
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 262.21M 264.30M 265.83M 266.94M 267.53M 268.10M 268.24M 268.15M 268.44M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.86 $3.50 $2.62 $2.78 $2.80 $2.52 $2.52 $2.92 $2.93
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 262.21M 264.30M 265.83M 266.94M 267.53M 268.10M 268.24M 268.15M 268.44M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 262.21M 264.30M 265.83M 266.94M 267.53M 268.10M 268.24M 268.15M 268.44M
Normalized Net Operating Profit after Tax (NOPAT)
449 486 569 651 790 817 856 727 800 851 858
Normalized NOPAT Margin
10.44% 11.02% 12.02% 12.28% 14.78% 14.58% 13.55% 11.45% 12.01% 12.65% 12.54%
Pre Tax Income Margin
11.55% 13.36% 12.57% 13.98% 15.32% 15.74% 14.18% 12.80% 11.99% 13.36% 13.35%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
10.31 11.52 7.22 5.25 5.96 7.50 7.56 6.45 4.84 5.29 5.65
NOPAT to Interest Expense
7.57 8.47 5.45 6.19 4.68 5.91 5.83 4.59 3.61 4.03 4.29
EBIT Less CapEx to Interest Expense
7.91 8.81 5.31 4.28 4.91 5.84 5.52 4.69 3.57 3.98 4.52
NOPAT Less CapEx to Interest Expense
5.16 5.76 3.55 5.22 3.63 4.25 3.80 2.83 2.35 2.71 3.16
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
51.02% 46.11% 49.77% 30.68% 43.01% 44.17% 48.10% 58.17% 61.49% 57.20% 61.19%
Augmented Payout Ratio
87.33% 97.50% 78.63% 37.36% 56.54% 50.50% 49.24% 63.86% 66.74% 63.93% 65.59%

Quarterly Metrics And Ratios for MCCORMICK & CO/SH SH

This table displays calculated financial ratios and metrics derived from MCCORMICK & CO/SH SH's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
DEI Shares Outstanding
- - - - - - - - 268,724,970.00 268,851,552.00 269,064,479.00
DEI Adjusted Shares Outstanding
- - - - - - - - 268,724,970.00 268,851,552.00 269,064,479.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 3.78 0.56 0.36
Growth Metrics
- - - - - - - - - - -
Revenue Growth
2.38% -0.96% -0.29% 2.58% 0.17% 0.99% 2.68% 2.91% 16.72% 16.70% 17.39%
EBITDA Growth
12.60% 7.24% 15.82% 2.48% -0.55% 3.00% 1.41% 3.12% 7.44% 13.98% -16.64%
EBIT Growth
16.42% 5.21% 18.88% 2.09% -3.92% 3.69% -0.53% 1.14% -1.15% 10.68% -25.23%
NOPAT Growth
11.41% 17.20% 24.02% -1.31% 0.62% -7.83% 1.74% 3.64% -4.20% 5.42% -39.52%
Net Income Growth
19.34% 21.10% 31.16% -1.87% -2.23% -4.99% 1.08% 5.30% 525.64% -8.98% -52.74%
EPS Growth
19.23% 21.43% 31.75% -2.47% -3.23% -4.41% 1.20% 6.33% 528.33% -13.85% -57.14%
Operating Cash Flow Growth
33.85% -43.91% -39.19% -20.53% -16.55% -71.86% 60.05% 18.16% -55.93% 727.45% -35.05%
Free Cash Flow Firm Growth
40.62% -15.41% -72.28% -65.62% -63.29% -128.37% -16.44% -35.69% -2,162.11% -2,801.56% -3,133.65%
Invested Capital Growth
-1.80% -0.56% 1.78% 1.09% 0.62% 2.97% 1.95% 1.75% 30.88% 25.31% 25.04%
Revenue Q/Q Growth
-8.56% 2.53% 2.23% 7.04% -10.71% 3.36% 3.94% 7.28% 1.27% 3.35% 4.55%
EBITDA Q/Q Growth
-19.18% 4.55% 16.70% 3.92% -21.56% 8.28% 14.90% 5.68% -18.28% 14.86% -15.97%
EBIT Q/Q Growth
-21.20% 0.78% 21.58% 5.74% -25.84% 8.77% 16.63% 7.51% -27.52% 21.78% -21.21%
NOPAT Q/Q Growth
-24.83% 16.40% 17.97% -4.39% -23.37% 6.63% 30.21% -2.60% -29.16% 17.35% -25.31%
Net Income Q/Q Growth
-24.30% 10.96% 21.12% -3.54% -24.58% 7.83% 28.86% 0.49% 351.15% -84.33% -32.83%
EPS Q/Q Growth
-23.46% 9.68% 22.06% -4.82% -24.05% 8.33% 29.23% 0.00% 348.81% -85.15% -35.71%
Operating Cash Flow Q/Q Growth
-76.02% 17.85% -0.86% 183.67% -74.82% -60.26% 463.83% 109.43% -90.61% 646.17% -55.74%
Free Cash Flow Firm Q/Q Growth
-16.59% -24.20% -66.71% 63.36% -10.93% -158.58% 198.04% 25.72% -2,956.07% 17.58% -2.51%
Invested Capital Q/Q Growth
2.52% 0.87% 2.19% -4.35% 2.05% 3.23% 1.18% -4.54% 31.26% -1.17% 0.96%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
37.39% 37.71% 38.69% 40.17% 37.62% 37.53% 37.40% 38.93% 37.83% 40.18% 39.26%
EBITDA Margin
18.12% 18.48% 21.09% 20.48% 17.99% 18.84% 20.83% 20.52% 16.56% 18.40% 14.79%
Operating Margin
14.57% 14.25% 17.06% 17.03% 14.03% 14.81% 16.74% 16.81% 12.14% 14.27% 10.72%
EBIT Margin
15.26% 15.00% 17.84% 17.63% 14.64% 15.40% 17.28% 17.32% 12.40% 14.61% 11.01%
Profit (Net Income) Margin
10.36% 11.21% 13.28% 11.97% 10.11% 10.55% 13.07% 12.25% 54.55% 8.27% 5.31%
Tax Burden Percent
85.43% 95.14% 90.62% 81.45% 87.02% 85.53% 90.96% 82.70% 552.59% 72.75% 69.64%
Interest Burden Percent
79.44% 78.54% 82.15% 83.37% 79.36% 80.05% 83.16% 85.49% 79.64% 77.84% 69.31%
Effective Tax Rate
25.53% 13.53% 16.65% 25.44% 22.31% 24.10% 15.85% 23.94% 26.32% 28.84% 32.30%
Return on Invested Capital (ROIC)
8.35% 9.44% 10.78% 10.10% 8.48% 8.59% 10.65% 10.20% 6.35% 7.44% 5.47%
ROIC Less NNEP Spread (ROIC-NNEP)
8.14% 8.93% 10.33% 9.70% 8.09% 8.24% 10.13% 9.87% 30.69% 6.39% 4.35%
Return on Net Nonoperating Assets (RNNOA)
5.82% 6.18% 6.97% 6.07% 4.98% 5.00% 6.06% 5.40% 16.57% 3.37% 2.28%
Return on Equity (ROE)
14.17% 15.62% 17.75% 16.17% 13.46% 13.59% 16.71% 15.60% 22.92% 10.81% 7.75%
Cash Return on Invested Capital (CROIC)
10.67% 9.73% 7.85% 8.89% 9.15% 6.47% 7.35% 8.08% -18.42% -14.09% -14.89%
Operating Return on Assets (OROA)
7.84% 7.74% 9.10% 9.14% 7.64% 7.93% 8.87% 9.02% 6.03% 7.27% 5.66%
Return on Assets (ROA)
5.32% 5.79% 6.77% 6.21% 5.27% 5.43% 6.71% 6.38% 26.52% 4.12% 2.73%
Return on Common Equity (ROCE)
14.11% 15.55% 17.66% 16.09% 13.39% 13.52% 16.62% 15.52% 21.86% 10.31% 7.40%
Return on Equity Simple (ROE_SIMPLE)
13.52% 13.88% 14.62% 0.00% 14.47% 13.85% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
174 202 239 228 175 187 243 237 168 197 147
NOPAT Margin
10.85% 12.32% 14.22% 12.70% 10.90% 11.24% 14.08% 12.79% 8.94% 10.16% 7.26%
Net Nonoperating Expense Percent (NNEP)
0.22% 0.51% 0.44% 0.40% 0.38% 0.35% 0.52% 0.33% -24.34% 1.05% 1.12%
Return On Investment Capital (ROIC_SIMPLE)
- - - 2.36% 1.79% 1.85% 2.40% 2.42% 1.34% 1.57% 1.17%
Cost of Revenue to Revenue
62.61% 62.29% 61.31% 59.83% 62.38% 62.47% 62.60% 61.07% 62.17% 59.82% 60.74%
SG&A Expenses to Revenue
22.56% 23.35% 21.52% 23.05% 23.59% 21.95% 20.44% 21.88% 24.35% 22.81% 21.55%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
22.82% 23.46% 21.63% 23.14% 23.59% 22.72% 20.66% 22.11% 25.69% 25.91% 28.54%
Earnings before Interest and Taxes (EBIT)
245 247 300 317 235 256 298 321 232 283 223
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
290 304 354 368 289 313 359 380 310 356 300
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.53 3.64 3.97 3.95 4.08 3.48 3.28 3.14 2.73 1.82 2.08
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.76 2.90 3.22 3.11 3.29 2.89 2.78 2.63 2.68 1.72 1.90
Price to Earnings (P/E)
13.88 14.21 14.67 13.92 14.78 13.20 12.73 11.94 8.08 5.45 6.60
Dividend Yield
2.31% 2.24% 2.06% 2.16% 2.07% 2.39% 2.52% 2.69% 2.58% 3.93% 3.49%
Earnings Yield
7.21% 7.04% 6.82% 7.18% 6.77% 7.58% 7.86% 8.38% 12.38% 18.35% 15.15%
Enterprise Value to Invested Capital (EV/IC)
2.54 2.62 2.81 2.84 2.93 2.55 2.45 2.42 2.06 1.51 1.67
Enterprise Value to Revenue (EV/Rev)
3.26 3.40 3.74 3.59 3.78 3.39 3.27 3.06 3.30 2.30 2.46
Enterprise Value to EBITDA (EV/EBITDA)
17.65 18.07 19.09 18.33 19.32 17.26 16.70 15.59 17.40 12.19 14.20
Enterprise Value to EBIT (EV/EBIT)
21.00 21.60 22.67 21.78 23.13 20.65 20.07 18.84 21.19 14.95 17.86
Enterprise Value to NOPAT (EV/NOPAT)
28.38 28.44 29.50 28.62 30.10 27.58 26.64 24.84 28.10 20.06 25.20
Enterprise Value to Operating Cash Flow (EV/OCF)
17.19 19.88 24.00 26.17 28.26 29.24 25.25 21.72 26.12 13.77 16.57
Enterprise Value to Free Cash Flow (EV/FCFF)
23.56 26.80 36.12 32.11 32.12 40.04 33.63 30.18 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.85 0.83 0.84 0.82 0.79 0.79 0.75 0.69 0.65 0.65 0.66
Long-Term Debt to Equity
0.63 0.62 0.61 0.68 0.57 0.55 0.54 0.54 0.48 0.48 0.38
Financial Leverage
0.72 0.69 0.67 0.63 0.62 0.61 0.60 0.55 0.54 0.53 0.52
Leverage Ratio
2.57 2.51 2.49 2.49 2.41 2.38 2.35 2.37 2.25 2.25 2.24
Compound Leverage Factor
2.04 1.97 2.05 2.08 1.91 1.91 1.96 2.03 1.79 1.75 1.55
Debt to Total Capital
45.88% 45.47% 45.70% 44.95% 44.15% 44.17% 42.97% 40.93% 39.45% 39.45% 39.81%
Short-Term Debt to Total Capital
11.61% 11.60% 12.40% 7.75% 12.42% 13.44% 12.36% 9.12% 10.57% 10.68% 16.76%
Long-Term Debt to Total Capital
34.27% 33.87% 33.30% 37.21% 31.73% 30.73% 30.61% 31.81% 28.88% 28.76% 23.05%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.26% 0.27% 0.29% 0.27% 0.27% 0.29% 0.30% 0.32% 4.61% 4.62% 4.63%
Common Equity to Total Capital
53.86% 54.26% 54.00% 54.78% 55.58% 55.54% 56.72% 58.75% 55.93% 55.93% 55.56%
Debt to EBITDA
3.60 3.55 3.51 3.30 3.28 3.36 3.28 2.98 3.66 3.55 3.77
Net Debt to EBITDA
2.72 2.65 2.63 2.42 2.45 2.51 2.47 2.15 2.82 2.62 2.81
Long-Term Debt to EBITDA
2.69 2.64 2.56 2.73 2.35 2.34 2.34 2.32 2.68 2.59 2.18
Debt to NOPAT
5.78 5.58 5.42 5.15 5.10 5.38 5.23 4.75 5.90 5.84 6.69
Net Debt to NOPAT
4.37 4.18 4.06 3.78 3.82 4.01 3.93 3.43 4.55 4.32 4.99
Long-Term Debt to NOPAT
4.32 4.16 3.95 4.26 3.67 3.74 3.73 3.69 4.32 4.26 3.87
Altman Z-Score
2.32 2.39 2.54 2.52 2.67 2.43 2.43 2.37 2.14 1.72 1.77
Noncontrolling Interest Sharing Ratio
0.42% 0.45% 0.48% 0.47% 0.48% 0.51% 0.54% 0.52% 4.63% 4.59% 4.60%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.68 0.69 0.71 0.74 0.65 0.68 0.71 0.70 0.76 0.78 0.66
Quick Ratio
0.25 0.26 0.27 0.27 0.20 0.22 0.24 0.24 0.29 0.29 0.26
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
332 251 84 137 122 -71 70 88 -2,511 -2,070 -2,121
Operating Cash Flow to CapEx
223.23% 238.80% 274.07% 535.86% 311.32% 95.03% 491.08% 647.55% 156.62% 889.46% 300.18%
Free Cash Flow to Firm to Interest Expense
6.59 4.75 1.56 2.59 2.51 -1.40 1.39 1.89 -53.09 -33.01 -31.02
Operating Cash Flow to Interest Expense
2.75 3.08 3.02 8.70 2.38 0.90 5.16 11.66 1.08 6.06 2.46
Operating Cash Flow Less CapEx to Interest Expense
1.52 1.79 1.92 7.08 1.62 -0.05 4.11 9.86 0.39 5.38 1.64
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.51 0.52 0.51 0.52 0.52 0.52 0.51 0.52 0.49 0.50 0.51
Accounts Receivable Turnover
11.77 11.57 10.39 11.45 12.41 11.40 10.21 11.25 10.56 11.42 10.25
Inventory Turnover
3.36 3.40 3.33 3.49 3.48 3.36 3.27 3.38 3.38 3.34 3.38
Fixed Asset Turnover
5.19 5.11 4.97 4.91 4.90 4.85 4.82 4.78 4.90 5.06 5.20
Accounts Payable Turnover
3.69 3.58 3.53 3.51 3.60 3.47 3.46 3.40 3.46 3.37 3.50
Days Sales Outstanding (DSO)
31.01 31.56 35.13 31.89 29.42 32.02 35.75 32.45 34.56 31.97 35.62
Days Inventory Outstanding (DIO)
108.53 107.30 109.64 104.50 104.94 108.59 111.67 107.91 108.06 109.34 107.93
Days Payable Outstanding (DPO)
99.03 101.83 103.40 104.10 101.40 105.18 105.51 107.29 105.63 108.41 104.36
Cash Conversion Cycle (CCC)
40.52 37.03 41.36 32.29 32.96 35.43 41.91 33.07 36.98 32.90 39.19
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
8,621 8,697 8,888 8,501 8,675 8,955 9,061 8,649 11,353 11,221 11,329
Invested Capital Turnover
0.77 0.77 0.76 0.80 0.78 0.76 0.76 0.80 0.71 0.73 0.75
Increase / (Decrease) in Invested Capital
-158 -49 155 92 53 258 173 149 2,679 2,266 2,268
Enterprise Value (EV)
21,866 22,754 24,964 24,129 25,404 22,858 22,193 20,897 23,443 16,955 18,903
Market Capitalization
18,477 19,385 21,498 20,919 22,152 19,505 18,885 17,984 19,070 12,730 14,577
Book Value per Share
$19.50 $19.85 $20.18 $19.72 $20.22 $20.89 $21.44 $21.37 $26.00 $26.03 $26.05
Tangible Book Value per Share
($12.55) ($12.18) ($11.87) ($12.13) ($11.53) ($11.18) ($10.67) ($10.65) ($16.01) ($15.76) ($15.84)
Total Capital
9,714 9,819 10,039 9,659 9,757 10,085 10,142 9,764 12,480 12,507 12,605
Total Debt
4,457 4,465 4,588 4,342 4,308 4,455 4,358 3,996 4,923 4,934 5,018
Total Long-Term Debt
3,329 3,326 3,343 3,594 3,096 3,099 3,105 3,106 3,604 3,597 2,906
Net Debt
3,364 3,343 3,437 3,184 3,225 3,324 3,277 2,881 3,797 3,648 3,742
Capital Expenditures (CapEx)
62 68 59 86 37 48 53 84 33 43 56
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3.70 58 144 -182 20 212 263 -130 309 222 266
Debt-free Net Working Capital (DFNWC)
174 224 345 4.50 123 336 357 -34 487 553 597
Net Working Capital (NWC)
-954 -915 -900 -744 -1,089 -1,019 -896 -924 -833 -783 -1,515
Net Nonoperating Expense (NNE)
7.89 18 16 13 13 12 17 10 -855 36 39
Net Nonoperating Obligations (NNO)
3,364 3,343 3,437 3,184 3,225 3,324 3,277 2,881 3,797 3,648 3,742
Total Depreciation and Amortization (D&A)
46 57 55 51 54 57 61 59 78 74 77
Debt-free, Cash-free Net Working Capital to Revenue
-0.06% 0.86% 2.16% -2.70% 0.30% 3.15% 3.87% -1.89% 4.34% 3.00% 3.46%
Debt-free Net Working Capital to Revenue
2.60% 3.35% 5.16% 0.07% 1.83% 4.99% 5.27% -0.49% 6.84% 7.49% 7.77%
Net Working Capital to Revenue
-14.23% -13.69% -13.48% -11.06% -16.19% -15.12% -13.20% -13.51% -11.72% -10.60% -19.71%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.62 $0.69 $0.83 $0.80 $0.60 $0.65 $0.84 $0.85 $3.78 $0.56 $0.36
Adjusted Weighted Average Basic Shares Outstanding
268.40M 268.60M 268.60M 268.15M 268.30M 268.60M 268.60M 268.44M 268.80M 269.20M 269.30M
Adjusted Diluted Earnings per Share
$0.62 $0.68 $0.83 $0.79 $0.60 $0.65 $0.84 $0.84 $3.77 $0.56 $0.36
Adjusted Weighted Average Diluted Shares Outstanding
269.60M 269.70M 269.70M 268.15M 269.50M 269.40M 269.30M 268.44M 269.40M 269.20M 269.40M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
268.41M 268.63M 268.36M 268.15M 268.19M 268.37M 268.38M 268.44M 268.72M 268.85M 269.06M
Normalized Net Operating Profit after Tax (NOPAT)
177 204 240 230 175 196 246 240 186 239 243
Normalized NOPAT Margin
11.05% 12.41% 14.31% 12.76% 10.90% 11.83% 14.27% 12.97% 9.93% 12.36% 11.99%
Pre Tax Income Margin
12.12% 11.78% 14.66% 14.69% 11.62% 12.33% 14.37% 14.81% 9.87% 11.37% 7.63%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.86 4.66 5.60 6.01 4.85 5.01 5.94 6.89 4.91 4.51 3.26
NOPAT to Interest Expense
3.46 3.83 4.46 4.33 3.61 3.66 4.84 5.09 3.54 3.14 2.15
EBIT Less CapEx to Interest Expense
3.63 3.37 4.50 4.39 4.08 4.06 4.89 5.09 4.22 3.83 2.44
NOPAT Less CapEx to Interest Expense
2.22 2.54 3.36 2.71 2.84 2.71 3.79 3.29 2.86 2.46 1.33
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
60.30% 58.79% 55.89% 57.20% 58.49% 60.21% 61.04% 61.19% 29.80% 31.11% 34.95%
Augmented Payout Ratio
64.89% 61.71% 60.69% 63.93% 67.41% 69.89% 67.89% 65.59% 31.53% 32.28% 36.04%

Financials Breakdown Chart

Key Financial Trends

McCormick & Company (NYSE:MKC) delivered stronger sales and cash generation in the second quarter of fiscal 2026, although profitability was pressured by special charges and higher interest expense. The company’s balance sheet has improved from 2025 levels, but leverage, working-capital needs and a substantial concentration of assets in goodwill and intangible assets remain important risks for investors.

Revenue growth and gross margins improved. Q2 2026 revenue increased to $1.94 billion from $1.66 billion in Q2 2025, a gain of approximately 16.7%. Gross profit rose 25.0% to $778.2 million, lifting the gross margin to roughly 40.2% from 37.5%. This continues a broader pattern of year-over-year revenue growth: Q2 revenue increased from $1.60 billion in 2023 to $1.64 billion in 2024, $1.66 billion in 2025 and $1.94 billion in 2026.

Operating performance was more mixed. Q2 2026 operating income rose 12.4% year over year to $276.4 million, but the operating margin declined to approximately 14.3% from 14.8%. Selling, general and administrative expense declined to $441.8 million from $456.3 million, but $60.0 million of other special charges significantly reduced the benefit from improved gross profit.

Consolidated net income declined to $160.2 million from $176.0 million in the comparable quarter, while diluted earnings per share fell to $0.56 from $0.65. Higher interest expense, which increased to $62.7 million from $51.0 million, also weighed on earnings. The Q1 2026 income statement included an $886.0 million “other adjustment” that sharply inflated reported quarterly net income and EPS; investors should avoid treating that figure as representative of recurring operating performance.

  • Sales momentum improved: Q2 2026 revenue grew approximately 16.7% year over year, the strongest comparable-quarter increase in the provided data.
  • Gross profitability strengthened: Gross profit increased to $778.2 million and the gross margin expanded to about 40.2%, compared with 37.5% in Q2 2025.
  • Operating cash flow rebounded sharply: Cash generated from operations reached $379.8 million in Q2 2026, compared with $45.9 million in Q2 2025 and $163.1 million in Q2 2024.
  • Working-capital cash flow turned favorable: Changes in operating assets and liabilities contributed $140.4 million of cash in Q2 2026, reversing the $198.0 million use of cash in Q1 2026.
  • Cash reserves improved: Cash and equivalents increased to $331.2 million at May 31, 2026, from $124.1 million one year earlier and $177.7 million at the end of Q1 2026.
  • Capital spending remained controlled: Q2 capital expenditures were $42.7 million, below the $48.3 million recorded in Q2 2025, despite the company’s larger asset base.
  • Shareholder distributions continued: The company paid $137.4 million in dividends during Q2 2026, and the quarterly dividend per share was $0.48, up from $0.45 in Q2 2025 and $0.42 in Q2 2024.
  • Liquidity improved but remains tight: Total current assets rose to $2.79 billion, but total current liabilities also increased to $3.57 billion. The resulting current ratio remained below 1.0, at approximately 0.78.
  • Reported earnings declined despite revenue growth: Q2 net income fell approximately 9.0% year over year, while diluted EPS declined from $0.65 to $0.56.
  • Leverage and asset concentration remain concerns: Short- and long-term debt totaled approximately $4.93 billion at May 31, 2026, while goodwill and intangible assets totaled about $11.23 billion, or roughly 68% of total assets.

McCormick’s cash-flow trend is encouraging. Operating cash flow was positive in every quarter provided, but it was notably volatile, ranging from $45.9 million in Q2 2025 to $542.0 million in Q4 2025 and $379.8 million in Q2 2026. The company has generally used operating cash to fund capital expenditures, dividends and debt service, although the Q1 2026 acquisition required $729.9 million of cash and contributed to substantial financing activity.

The balance sheet has expanded meaningfully since Q2 2025, with total assets rising from $13.19 billion to $16.48 billion and total equity increasing from $5.35 billion to $7.57 billion. However, total debt has also increased from approximately $4.75 billion to $4.93 billion. Although Q2 financing activity included $40.2 million of debt repayment, the company remains dependent on continued cash generation and access to financing to support its dividend and acquisition strategy.

Overall, the statements point to improving demand, stronger gross margins and a significant cash-flow recovery. The key question for MKC investors is whether these gains can translate into sustained operating-margin and earnings growth after special charges, interest expense and acquisition-related costs. The company’s dividend appears supported by current operating cash flow, but the below-1.0 current ratio and high debt and intangible-asset balances warrant continued monitoring.

10/06/26 07:27 AM ETAI Generated. May Contain Errors.

MCCORMICK & CO/SH SH Financials - Frequently Asked Questions

According to the most recent income statement we have on file, MCCORMICK & CO/SH SH's financial year ends in November. Their financial year 2025 ended on November 30, 2025.

MCCORMICK & CO/SH SH's net income appears to be on an upward trend, with a most recent value of $789.40 million in 2025, rising from $401.60 million in 2015. The previous period was $788.50 million in 2024.

MCCORMICK & CO/SH SH's total operating income in 2025 was $1.07 billion, based on the following breakdown:
  • Total Gross Profit: $2.59 billion
  • Total Operating Expenses: $1.52 billion

Over the last 10 years, MCCORMICK & CO/SH SH's total revenue changed from $4.30 billion in 2015 to $6.84 billion in 2025, a change of 59.2%.

In the past 11 quarters, MCCORMICK & CO/SH SH's cash and equivalents has ranged from $94.90 million in Q3 2025 to $331.20 million in Q2 2026, and is currently $331.10 million as of their latest financial filing in Q3 2026.

MCCORMICK & CO/SH SH had total debt of $4.00 billion at the end of 2025, a 8.0% decrease from 2024, and a 186.6% increase since 2015.

Over the last 10 years, MCCORMICK & CO/SH SH's book value per share changed from 13.04 in 2015 to 21.37 in 2025, a change of 63.9%.



Financial statements for NYSE:MKC.V last updated on 10/1/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners